Issues in Mandatory Economic Assessment of Pharmaceuticals
Open Access
- 1 January 1992
- journal article
- editorial
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 11 (4) , 197-201
- https://doi.org/10.1377/hlthaff.11.4.197
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Cost of innovation in the pharmaceutical industryJournal of Health Economics, 1991
- Avoiding Bias in the Conduct and Reporting of Cost-Effectiveness Research Sponsored by Pharmaceutical CompaniesNew England Journal of Medicine, 1991
- Post-marketing studies of drug efficacy: Why?The American Journal of Medicine, 1985
- Postmarketing studies of drug efficacy: When must they be randomized?Clinical Pharmacology & Therapeutics, 1983